Skip to main content
Erschienen in: Supportive Care in Cancer 7/2011

01.07.2011 | Original Article

Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy

verfasst von: Stéphane Vignes, Raphaël Porcher, Maria Arrault, Alain Dupuy

Erschienen in: Supportive Care in Cancer | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Lymphedema treatment is based on an intensive decongestive physiotherapy phase of volume reduction followed by a long-term maintenance phase. Factors influencing the morbid lymphedema volume increase during maintenance were analyzed.

Materials and methods

Among 867 consecutive women recruited and followed in a single lymphology unit, 682 were analyzed. The other 185 were not analyzed because of an initial lymphedema volume <250 ml, <20% lymphedema volume decrease during the intensive phase, or they were lost to follow-up. Lymphedema volume was recorded prior to and at the end of intensive phase, and at each follow-up visit. During follow-up, treatment failure was defined as a lymphedema volume increase of ≥50% of the total reduction obtained during the intensive phase.

Results

Median lymphedema volume was 936 ml before and 335 ml after intensive decongestive physiotherapy (P < 0.0001). Median follow-up was 28 months. During the maintenance phase, the risk of treatment failure at 1, 2, and 4 years was estimated to be 38.1%, 53.1%, and 64.8%, respectively. Wearing an elastic sleeve during the day and an overnight multilayer low-stretch bandage (median, four nights per week; interquartile range, 2–6) significantly decreased the risk of treatment failure [hazard ratio, 0.53, (0.34–0.82), P = 0.004], whereas manual lymph drainage adjunction to those therapeutic components did not. The risk of treatment failure was also associated with weight and body mass index at inclusion.

Conclusion

Risk of maintenance-therapy failure after intensive decongestive physiotherapy was associated with patients characteristics (younger age, higher weight, and body mass index), while elastic sleeve and bandage were associated with better maintenance results. Paradoxical effect of manual lymph drainage is likely to be related to indication bias.
Literatur
1.
Zurück zum Zitat Lucci A, McCall LM, Beitsch PD et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663PubMedCrossRef Lucci A, McCall LM, Beitsch PD et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663PubMedCrossRef
2.
Zurück zum Zitat Langer I, Guller U, Berclaz G et al (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245:452–461PubMedCrossRef Langer I, Guller U, Berclaz G et al (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245:452–461PubMedCrossRef
3.
Zurück zum Zitat McLaughlin SA, Wright MJ, Morris KT et al (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26:5213–5219PubMedCrossRef McLaughlin SA, Wright MJ, Morris KT et al (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26:5213–5219PubMedCrossRef
4.
Zurück zum Zitat Heiney SP, McWayne J, Cunningham JE et al (2007) Quality of life and lymphedema following breast cancer. Lymphology 40:177–184PubMed Heiney SP, McWayne J, Cunningham JE et al (2007) Quality of life and lymphedema following breast cancer. Lymphology 40:177–184PubMed
5.
Zurück zum Zitat Harris SR, Hugi MR, Olivotto IA, Levine M, Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (2001) Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ 164:191–199PubMed Harris SR, Hugi MR, Olivotto IA, Levine M, Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer (2001) Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ 164:191–199PubMed
6.
Zurück zum Zitat Lymphoedema Framework (2006) Best practice for the management of lymphoedema. International consensus. MEP Ltd, London Lymphoedema Framework (2006) Best practice for the management of lymphoedema. International consensus. MEP Ltd, London
7.
Zurück zum Zitat Cheville AL, McGarvey CL, Petrek JA et al (2003) Lymphedema management. Semin Radiat Oncol 13:290–301PubMedCrossRef Cheville AL, McGarvey CL, Petrek JA et al (2003) Lymphedema management. Semin Radiat Oncol 13:290–301PubMedCrossRef
8.
Zurück zum Zitat Szuba A, Cooke JP, Yousuf S, Rockson SG (2000) Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema. Am J Med 109:296–300PubMedCrossRef Szuba A, Cooke JP, Yousuf S, Rockson SG (2000) Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema. Am J Med 109:296–300PubMedCrossRef
9.
Zurück zum Zitat Ko DS, Lerner R, Klose G, Cosimi AB (1998) Effective treatment of lymphedema of the extremities. Arch Surg 133:452–458PubMedCrossRef Ko DS, Lerner R, Klose G, Cosimi AB (1998) Effective treatment of lymphedema of the extremities. Arch Surg 133:452–458PubMedCrossRef
10.
Zurück zum Zitat Shaw C, Mortimer P, Judd PA (2007) A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema. Cancer 110:1868–1874PubMedCrossRef Shaw C, Mortimer P, Judd PA (2007) A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema. Cancer 110:1868–1874PubMedCrossRef
11.
Zurück zum Zitat Sitzia J (1995) Volume measurement in lymphoedema treatment: examination of formulae. Eur J Cancer Care 4:11–16CrossRef Sitzia J (1995) Volume measurement in lymphoedema treatment: examination of formulae. Eur J Cancer Care 4:11–16CrossRef
12.
Zurück zum Zitat Galland C, Auvert JF, Flahault A, Vayssairat M (2002) Why and how post-mastectomy edema should be quantified in patients with breast cancer. Breast Cancer Res Treat 75:87–89PubMedCrossRef Galland C, Auvert JF, Flahault A, Vayssairat M (2002) Why and how post-mastectomy edema should be quantified in patients with breast cancer. Breast Cancer Res Treat 75:87–89PubMedCrossRef
13.
Zurück zum Zitat Boris M, Weindorf S, Lasinski B (1997) Persistence of lymphedema reduction after noninvasive complex lymphedema therapy. Oncology (Williston Park) 11:99–109, discussion 110, 113–114 Boris M, Weindorf S, Lasinski B (1997) Persistence of lymphedema reduction after noninvasive complex lymphedema therapy. Oncology (Williston Park) 11:99–109, discussion 110, 113–114
14.
Zurück zum Zitat Vignes S, Porcher R, Arrault M, Dupuy A (2007) Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy. Breast Cancer Res Treat 101:285–29PubMedCrossRef Vignes S, Porcher R, Arrault M, Dupuy A (2007) Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy. Breast Cancer Res Treat 101:285–29PubMedCrossRef
15.
Zurück zum Zitat Torres Lacomba M, Yuste Sánchez MJ, Zapico Goñi A et al (2010) Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ 340:b5396. doi:10.1136/bmj.b5396 PubMedCrossRef Torres Lacomba M, Yuste Sánchez MJ, Zapico Goñi A et al (2010) Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ 340:b5396. doi:10.​1136/​bmj.​b5396 PubMedCrossRef
16.
Zurück zum Zitat Kocak Z, Overgaard J (2000) Risk factors of arm lymphedema in breast cancer patients. Acta Oncol 39:389–392PubMedCrossRef Kocak Z, Overgaard J (2000) Risk factors of arm lymphedema in breast cancer patients. Acta Oncol 39:389–392PubMedCrossRef
17.
Zurück zum Zitat Petrek JA, Senie RT, Peters M, Rosen PP (2001) Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 92:1368–1377PubMedCrossRef Petrek JA, Senie RT, Peters M, Rosen PP (2001) Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 92:1368–1377PubMedCrossRef
18.
Zurück zum Zitat Vignes S, Arrault M, Dupuy A (2007) Factors associated with increased breast cancer-related lymphedema volume. Acta Oncol 46:1138–1142PubMedCrossRef Vignes S, Arrault M, Dupuy A (2007) Factors associated with increased breast cancer-related lymphedema volume. Acta Oncol 46:1138–1142PubMedCrossRef
Metadaten
Titel
Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy
verfasst von
Stéphane Vignes
Raphaël Porcher
Maria Arrault
Alain Dupuy
Publikationsdatum
01.07.2011
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 7/2011
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-0906-x

Weitere Artikel der Ausgabe 7/2011

Supportive Care in Cancer 7/2011 Zur Ausgabe

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.